Provation Acquires Perioperative Data Management Platform iProcedures
What You Should Know:
– Provation, a SaaS provider of procedure documentation and clinical decision support solutions, backed by Clearlake Capital Group, L.P. (together with its affiliates, “Clearlake”), today announced its acquisition of iProcedures, LLC, a top-rated provider of cloud-based anesthesia documentation and perioperative data management software solutions. Financial terms of the transaction were not disclosed.
– The acquisition further expands Provation’s industry-leading anesthesia expertise and its portfolio of end-to-end clinical productivity and documentation software and SaaS solutions.
– Together, iProcedures and Provation become an industry leader in both GI and anesthesia with end-to-end clinical productivity solutions that span the entire perioperative continuum and improve clinical documentation, efficiency in OR, PACU, and PAT processes, quality reporting, reimburseme
What You Should Know:
– B. Braun Medical Inc. (B. Braun), a provider of infusion therapy and pain management, unveiled Peripheral Advantage, a new program that is designed to improve patients’ experience with peripheral intravenous (IV) therapy.
– The comprehensive program combines clinical instruction, data-driven insights and advanced tools to empower nurses to achieve first-stick success and help prevent many of the complications associated with peripheral IV therapy.
– Peripheral Advantage, which is now available to all hospitals nationwide, addresses a long tolerated, yet unacceptable reality: Although vascular access is the most common invasive procedure, most nurses are not provided with the training, techniques or tools they need to achieve first-stick success.
To print this article, all you need is to be registered or login on Mondaq.com.
Though often lauded as a medical miracle, vaccinations have
joined the ranks of staunchly polarizing topics. Complicating
matters of polite avoidance, the objective of vaccines, to
eradicate disease, sits squarely in the crossfires of a public
interest versus personal autonomy balancing act. As two COVID-19
vaccines have been given emergency use authorization, employers now
find themselves facing the daunting task of resolving yay or nay on
requiring mandatory employee vaccinations, and if the former, how
to create said policy. This article discusses the history of
CVS Health Launches Employer-Based COVID-19 Vaccination Program
What You Should Know:
Today, CVS Health announced it recently began administering COVID-19 vaccines at employer-based vaccination clinics through Return Ready, the company’s comprehensive COVID-19 solution that helps employers return and maintain healthy workforces.
– With vaccine hesitancy on the rise, federal and state governments are looking to partners, like employers and CVS Health, to help by making vaccines more convenient to access and enhancing public education efforts.
To date, CVS Health has launched vaccine clinics for 18 employers across 51 locations, beginning with Delta Air Lines in February 2021, which built on the company’s partnership in administering COVID-19 testing to employees since the summer of 2020. The New York Shipping Association and The City of Philadelphia are also working with CVS Health to deploy vaccination sites for employees.
Glytec Raises $21M to Fix Hospital Insulin Management
What You Should Know:
– Glytec announced $21M in funding today from Silicon Valley Bank, Savitr Capital and others to help address the challenge that 90% of hospitals in the U.S. face with insulin management.
– Glytec’s insulin management solution, eGMS helps providers track blood glucose data, detect and alert patients in glycemic disarray, provide personalized insulin dosing regimens, and get patients into target blood glucose range quickly and safely. Glytec will use the new investments to increase engineering, product and other key department headcounts by more than 30% in 2021 to help scale its flagship product.